November 6th, 2026Maternal RSVpreF 78% effective against infant RSV hospitalizationA meta-analysis of 7 real-world studies found maternal RSVpreF 78% effective against RSV LRTI hospitalization in infants up to 6 months.Read more
November 5th, 2026Breastfeeding essentials: Assessing latch and milk transferJessica Nash, MD, IBCLC, shares strategies for assessing breastfeeding, identifying latch problems, and connecting families with lactation resources.Read more
October 22nd, 2026Menstrual irregularities in adolescents: When to investigateNikta Forghani, MD, explains when irregular menstrual cycles warrant evaluation and how pediatricians can identify PCOS and relative energy deficiency.Read more
October 22nd, 2026Low third-trimester PlGF linked to later ADHD in offspringLower maternal PlGF in the third trimester was tied to child ADHD in a University of Iowa cohort, independent of preeclampsia and FGR.Read more
November 16th, 2026Tirzepatide cuts BMI 18.5% in adolescents with obesityIn SURMOUNT-ADOLESCENTS, tirzepatide cut BMI 18.5% at 72 weeks vs a 0.5% rise with placebo in adolescents with obesity.Read more
November 16th, 2026Maternal autoantibodies linked to autism subtype, recurrence riskData presented at NSGC 2026 tie maternal autoantibody combinations to a non-genetic autism subtype with high recurrence risk in later-born siblings.Read more
November 16th, 2026Roflumilast cream 0.05% eases itch, improves QOL in infants with ADCaregivers reported itch, symptom, and QOL gains with roflumilast cream 0.05% in infants with AD; an FDA decision is due February 2027.Read more
November 16th, 2026Etavopivat for sickle cell disease submitted to FDA and EMANovo Nordisk filed etavopivat for SCD in patients aged 12+, backed by phase 3 HIBISCUS data showing a 27% drop in vaso-occlusive crises vs placebo.Read more